Skip to content
10-Q

Quarterly Report

GoHealth, Inc. GOCO GOCOQ

0001628280-26-035953

← back to feed
Filed
May 18, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 16.2M sh
Shares Diluted Q1 2026 · Mar 31, 2025 10.37M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $3.05M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $6.99M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$12.41M
Long Term Debt Q1 2026 · Mar 31, 2026 $650.76M
Long Term Debt Q1 2026 · Dec 31, 2025 $636.74M
Short Term Debt Q1 2026 · Mar 31, 2026 $2.38M
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $39.88M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $32.9M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.13M
Stockholders Equity Q1 2026 · Dec 31, 2025 $37.87M
Current Liabilities Q1 2026 · Mar 31, 2026 $130.24M
Current Liabilities Q1 2026 · Dec 31, 2025 $141.5M
Current Assets Q1 2026 · Mar 31, 2026 $264.9M
Current Assets Q1 2026 · Dec 31, 2025 $285.79M
Total Assets Q1 2026 · Mar 31, 2026 $917.92M
Total Assets Q1 2026 · Dec 31, 2025 $987.38M
Eps Diluted Q1 2026 · Mar 31, 2026 −$2.36
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.52
Eps Basic Q1 2026 · Mar 31, 2026 −$2.36
Eps Basic Q1 2026 · Mar 31, 2025 −$0.52
Sga Expense Q1 2026 · Mar 31, 2026 $21.69M
Sga Expense Q1 2026 · Mar 31, 2025 $22.66M
Net Income Q1 2026 · Mar 31, 2026 −$37.17M
Net Income Q1 2026 · Mar 31, 2025 −$4.41M
Operating Income Q1 2026 · Mar 31, 2026 −$34.79M
Operating Income Q1 2026 · Mar 31, 2025 $6.67M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $8.32M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $39.27M
Revenue Q1 2026 · Mar 31, 2026 $11.91M
Revenue Q1 2026 · Mar 31, 2025 $220.97M